So exciting to see @CovidHep & @SecureLiver data published in @Nature
It helps support a huge body of work led by @BreviniTeresa & @FSampaziotis showing that FXR inhibition (e.g UDCA) may protect from SARS-CoV-2 by reducing ACE2. Very cool. #livertwitter
https://t.co/PcZac0fDdL
Excited to announce that a paper on the role of FXR inhibition in COVID-19 resulting from an international collaborative effort led by @BreviniTeresa and Fotios Sampaziotis and using data from @SecureLiver and @CovidHep is now online in @Nature
Fantastic talk by @tom_marjot at @EASLnews#ILC2022 on COVID-19 vaccine responses among patients with cirrhosis, post-LT, AIH and vascular liver disease vs healthy controls
Impressive, granular data on immune response after COVID-19 vaccination in vulnerable populations
SECURE-Liver and COVID-Hep registries aim to assess outcomes of COVID-19 in patients with chronic liver disease and prior liver transplant. If you are a researcher interested in accessing this data, apply today! https://t.co/uKDudWlw76
📢Do you have an important new research question relating to #COVID-19 & liver disease?
@CovidHep & @SecureLiver with @EASLnews & @AASLDtweets are now inviting applications to access international data for >1800 cases
To learn more visit🔗https://t.co/IJchkv7dSW
#LiverTwitter
📢BIG ANNOUNCEMENT
We are accepting applications to access data from @SecureLiver and @CovidHep to use for your research!
• >1800 cases of COVID-19 since pandemic onset
• Answer novel questions on COVID-19 and liver disease
To learn more visit https://t.co/UbpfzkdLGJ
Excited to be speaking about COVID-19 in patients with chronic liver disease at the KASL-@AASLDtweets joint symposium at #KDDW21 this evening
Session chairs: Joong-Won Park and Steven Flamm
Talks from @elizabeth_verna on COVID-19 and LT and Won Suk Choi on COVID-19 vaccination!
Well delivered and important talk from @docbinujohn at @AASLDtweets#LiverMtg21 presidential plenary
SARS-CoV-2 vaccination associated with large reductions in COVID-19 infections and death among liver transplant recipients
Protection appears > antibody response
Work from @SecureLiver and @CovidHep on post-vaccination infections among patients with chronic liver disease and liver transplant recipients in @HepCommJournal
Hospitalizations lower after vaccination in CLD and LT and 0 deaths among fully vaccinated
https://t.co/NduvSWPxM4
Big thanks to @tom_marjot for the fantastic overview of #COVID19 and liver disease! Highlighting amazing collaborative work from @CovidHep & @SecureLiver over the pandemic resulting in important learning points in caring for our liver patients. @EleanorBarnesOx#livertwitter
@SECURELiver Registry seeks case report submissions on lab-confirmed cases of COVID-19 in patients with liver disease or prior liver transplantation. Case report form available in English, French & Spanish #LiverTwitter
Learn more & submit a case report: https://t.co/IGQpYjzQvN
¡El relanzamiento de @SecureLiver y @CovidHep ya está disponible en español!
Tómese 5 minutos para contribuir a los casos de COVID-19 confirmados por laboratorio en pacientes con enfermedad hepática o trasplante de hígado previo.
SECURE-Liver/COVID-Hep:
https://t.co/KN542B9rE4
SECURE-Liver et COVID-Hep relancés sont désormais disponibles en français!
Prenez 5 minutes pour apporter votre contribution dans le cadre des cas de COVID-19 confirmés en laboratoire chez les patients.
SECURE-Liver/COVID-Hep: https://t.co/ogEF4iEmpd
¡El relanzamiento de SECURE-Liver y COVID-Hep ya está disponible en español!
Tómese 5 minutos para contribuir a los casos de COVID-19 confirmados por laboratorio en pacientes con enfermedad hepática o trasplante de hígado previo.
SECURE-Liver/COVID-Hep: https://t.co/ogEF4iEmpd
Congratulations to @tom_marjot for receiving the @EASLedu Award for his incredible work on the @CovidHep registry!
Our work continues and we encourage you to submit cases at https://t.co/m3xUrhzfvB (North or South America, China/Japan/Korea) and https://t.co/PyK5HrLJr3 (others).